• Narrow screen resolution
  • Wide screen resolution
  • Decrease font size
  • Default font size
  • Increase font size

ja_mageia

Expert Pearls

Hepatic Steatosis (non-alcholic fatty liver disease) - docosahexaenoic acid (DHA), algae schyzochitrium - 48467

Docosahexaenoic acid (DHA) from the algae Schyzochitrium at 250 mg or 500 mg per day. [Arch Dis Child, 2011, Jan 12; [Epub ahead of print]. 48467 (3/2011)] Summary Interview PubMed

Hepatic Steatosis (non-alcoholic fatty liver disease) - Antioxidants

Antioxidants (glutathione, β-carotene, vitamins E and C, N-acetylcystiene) and reduction of obesity. [J. Investigat Med, December 2004;52(8):506-514. 42725 (04/2005)] Summary Interview

Hepatic Steatosis (non-alcoholic fatty liver disease) - Betaine

Betaine 20 mg/d in divided doses. [Am J Gastroenterol, 2003;98(11):2485-2490. 41351 (2004)] Summary Interview

Hepatic Steatosis (non-alcoholic fatty liver disease) - Eicosapentaeonoic Acid

Eicosapentaeonoic Acid (EPA) 356 mg/d and docosahexaenoic acid (DHA) 594 mg/d. [Aliment Pharmacol Ther, 2006 Apr 15;23 (8):1143-51. 44282/44872 (7/2006)] Summary Interview

Hepatic Steatosis (non-alcoholic fatty liver disease) - Vitamin C

Vitamin C 1000 mg/d and vitamin E 1000 mg/d. [Am J Gastroenterol, 2003;98 (11):2485-2490. 41351 (2004)] Summary Interview
Powered by Sigsiu.NET RSS Feeds